LIN.US

480.83

-1.42%↓

BHP.UK

2,540

+0.16%↑

BHP.US

68.01

-0.13%↓

RIO.US

85.19

-0.92%↓

SCCO

155.63

-3.05%↓

LIN.US

480.83

-1.42%↓

BHP.UK

2,540

+0.16%↑

BHP.US

68.01

-0.13%↓

RIO.US

85.19

-0.92%↓

SCCO

155.63

-3.05%↓

LIN.US

480.83

-1.42%↓

BHP.UK

2,540

+0.16%↑

BHP.US

68.01

-0.13%↓

RIO.US

85.19

-0.92%↓

SCCO

155.63

-3.05%↓

LIN.US

480.83

-1.42%↓

BHP.UK

2,540

+0.16%↑

BHP.US

68.01

-0.13%↓

RIO.US

85.19

-0.92%↓

SCCO

155.63

-3.05%↓

LIN.US

480.83

-1.42%↓

BHP.UK

2,540

+0.16%↑

BHP.US

68.01

-0.13%↓

RIO.US

85.19

-0.92%↓

SCCO

155.63

-3.05%↓

Search

Martin Marietta Materials Inc

Open

SectorGrondstoffen

575.77 -1.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

565.94

Max

587.45

Belangrijke statistieken

By Trading Economics

Inkomsten

-135M

279M

Verkoop

-312M

1.5B

K/W

Sectorgemiddelde

35.843

34.302

EPS

4.62

Dividendrendement

0.56

Winstmarge

18.188

Werknemers

9,600

EBITDA

-29M

493M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+26.14% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.56%

2.86%

Volgende Winsten

29 apr 2026

Volgende dividenddatum

31 mrt 2026

Volgende Ex Dividend datum

1 jun 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-6.7B

35B

Vorige openingsprijs

576.97

Vorige sluitingsprijs

575.77

Nieuwssentiment

By Acuity

73%

27%

145 / 151 Rangschikking in Basic materials

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Martin Marietta Materials Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Martin Marietta Materials Inc Prognose

Koersdoel

By TipRanks

26.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 707.23 USD  26.14%

Hoogste 804 USD

Laagste 612 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Martin Marietta Materials Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

8

Buy

7

Hold

0

Sell

Technische score

By Trading Central

533.69 / 542.19Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Sentiment

By Acuity

145 / 151 Rangschikking in Grondstoffen

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Martin Marietta Materials Inc

Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally. It offers crushed stone, sand, and gravel products; ready mixed concrete and asphalt; paving products and services; and Portland and specialty cement for use in the infrastructure projects, and nonresidential and residential construction markets, as well as in the railroad, agricultural, utility, and environmental industries. The company also produces magnesia-based chemicals products; dolomitic lime primarily to customers for steel production and soil stabilization; and cement treated materials. Its chemical products are used in flame retardants, wastewater treatment, pulp and paper production, and other environmental applications. The company was founded in 1939 and is headquartered in Raleigh, North Carolina.
help-icon Live chat